Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis
- 14 February 2017
- journal article
- research article
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 13 (2) , 129-135
Abstract
The cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation identification is being used with increased frequency to aid in the diagnosis of cystic fibrosis (CF) in those suspected with CF. Aim of this study was to identify diagnostic outcomes when CFTR mutational analysis was used in CF diagnosis. CFTR mutational analysis results were also compared with sweat chloride results.Keywords
This publication has 8 references indexed in Scilit:
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator geneNature Genetics, 2013
- A continuing role for sweat testing in an era of newborn screening for cystic fibrosisClinical Biochemistry, 2011
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus ReportThe Journal of Pediatrics, 2008
- Atypical Cystic Fibrosis and CFTR-Related DiseasesClinical Reviews in Allergy & Immunology, 2008
- Cystic FibrosisNew England Journal of Medicine, 2005
- Nonclassic cystic fibrosis and CFTR-related diseasesCurrent Opinion in Pulmonary Medicine, 2003
- Cystic fibrosisThe Lancet, 2003
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989